Velocity rozszerza swoją działalność na 17 ośrodków w Europie
03 janv. 2024 03h00 HE | Velocity Clinical Research, Inc.
Firma Velocity będąca największą w Stanach Zjednoczonych siecią ośrodków badań klinicznych staje się również jedną z największych sieci ośrodków badań klinicznych w Europie.Dodaje onkologię do...
Od lewej do prawej: Dr. Grzegorz Kania; Dr. Agnieszka Gackowska
Velocity Clinical Research rozszerza działalność na Polskę
06 déc. 2023 06h00 HE | Velocity Clinical Research, Inc.
Sieć silnych polskich ośrodków badwczych w planach nabycia do końca 2023 rokuZatrudnienie byłej Globalnej Szefowej ds. Rozwiązań w Ośrodkach Badwczych (Global Head Site Solutions)w firmie Parexel,...
From left to right: Dr Grzegorz Kania and Dr Agnieszka Gackowska
Velocity Clinical Research expands to Poland
06 déc. 2023 06h00 HE | Velocity Clinical Research, Inc.
Strong pipeline of Polish acquisition targets by end of 2023Hires ex-Parexel Global Head Site Solutions to lead Polish expansion LONDON, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Velocity Clinical Research...
Velocity baut MASH/MASLD-Kapazitäten mit jüngsten Standortübernahmen aggressiv aus
26 oct. 2023 05h28 HE | Velocity Clinical Research, Inc.
• Gewinnung von zwei Meinungsbildnern: Dr. Kris Kowdley und Dr. Nadege Gunn • Aufbau auf bestehenden MASH/MASLD-Fähigkeiten an 23 Standorten weltweit DURHAM, North Carolina, Oct. 26, 2023 (GLOBE...
MASH PIs - Velocity (1)
Velocity aggressively expands MASH/MASLD capabilities with latest site acquisitions
25 oct. 2023 07h04 HE | Velocity Clinical Research, Inc.
• Add two KOLs: Dr Kris Kowdley and Dr Nadege Gunn • Builds on existing MASH/MASLD capabilities at 23 sites globally DURHAM N.C., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Velocity Clinical...
New Principal Investigators at Velocity Clinical Research. From left to right: Shilpa Muthusamy, MD, Matt Fisher, MD
Velocity opens three U.K. greenfield clinical research sites
04 oct. 2023 04h36 HE | Velocity Clinical Research, Inc.
LONDON, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Velocity Clinical Research (“Velocity”), the leading multi-specialty clinical sites business, announced it is opening greenfield clinical research sites in...
Dr. Paul Evans, Chief Executive and President of Velocity
Velocity and Privia Health Enter Partnership to Embed Clinical Research Into Practice Sites
11 juil. 2023 07h09 HE | Velocity Clinical Research, Inc.
Partnership builds on Velocity’s embedded site model strategy and expands access to clinical trials for Privia Health patients and providersFirst site will open in Abilene, TX DURHAM, N.C., July 11,...
Dr. Paul Evans, Chief Executive and President of Velocity
Velocity Clinical Research acquires Meridian Clinical Research creating largest global research sites business
15 déc. 2022 06h00 HE | Velocity Clinical Research, Inc.
DURHAM, N.C., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Velocity Clinical Research (“Velocity”), the leading integrated research site organization, today announces its acquisition of Meridian Clinical...
Velocity_Press-Release-Image_121122_News-site_Long2
Velocity Clinical Research expands to UK
17 nov. 2022 02h00 HE | Velocity Clinical Research, Inc.
LONDON, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Velocity Clinical Research (“Velocity”), the leading integrated research site organisation, today announces its expansion into the U.K. with the acquisition...
Velocity_Patient-Report-2022_Press-release_v1
Velocity Clinical Research reveals findings from US patient survey on decentralization in clinical research
28 sept. 2022 07h30 HE | Velocity Clinical Research, Inc.
Patient-facing technology use is not as widespread as expected, although patients are very open to its useAn overwhelming majority of do not want home visitsYoung adults (ages 18-34) are taking part...